Nivolumab in patients with metastatic castration-resistant prostate cancer with and without DNA repair defects. Isaacsson Velho P, Bastos DA, Saint'ana PT, Rigatti B, et al. Clin Cancer Res 2024 Sep 27. doi: 10.1158/1078-0432.CCR-24-1595.

Read + Share

Amedeo Smart

Independent Medical Education

Isaacsson Velho P, Bastos DA, Saint'ana PT, Rigatti B, et al. Nivolumab in patients with metastatic castration-resistant prostate cancer with and without DNA repair defects. Clin Cancer Res 2024 Sep 27. doi: 10.1158/1078-0432.CCR-24-1595.
PMID: 39330991